LOGIN TO YOUR ACCOUNT

Username
Password
Remember Me
Or use your Academic/Social account:

CREATE AN ACCOUNT

Or use your Academic/Social account:

Congratulations!

You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.

Important!

Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message

CREATE AN ACCOUNT

Name:
Username:
Password:
Verify Password:
E-mail:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Malmborg, Rasmus; Mann, Gillian; Squire, Bertie (2011)
Publisher: Springer Nature
Journal: International Journal for Equity in Health
Languages: English
Types: Article
Subjects: wf_205_1, access, cost, Tuberculosis, wa_110, treatment outcome, equity, Research, Health Policy, RA1-1270, Public aspects of medicine, Public-Private Mix, case detection, Public Health, Environmental and Occupational Health

Abstract

Introduction

The STOP TB Partnership aims to improve global tuberculosis (TB) control through expanding access to the directly observed treatment short course (DOTS) strategy. One approach to this is 'Engaging all Care Providers', which evolved from 'Public-Private Mix (PPM) DOTS'. The overall aim of this study was to systematically assess whether and to what degree the STOP TB Partnership's four global objectives of engaging all care providers are met through existing PPM interventions. These four objectives are; 1) Increase TB case detection; 2) Improve TB treatment outcomes; 3) Enhance access and equity; 4) Reduce financial burden on patients. The specific objectives of this assessment were to 1) Understand what PPM means to the STOP TB Partnership's PPM Subgroup and to National Tuberculosis Programme managers; 2) Scope the nature of existing country-level PPM interventions and 3) Review PPM practice against the global PPM objectives.

Methods

We undertook a systematic, multi-facetted assessment. The methods included interviews with National Tuberculosis Programme managers from high burden countries, clarification of key issues with the STOP TB Partnership PPM secretariat and a review of publicly accessible reports and published articles on PPM projects. Both the literature review and interviews with the National Tuberculosis Programme managers yielded data on project characteristics; PPM models at country level; National Tuberculosis Programme partners; and mechanisms for engagement. Matrices were developed from the literature review and the interviews to show the relationship between services and service providers for different PPM projects. Data from the literature were assessed against each of the four global PPM objectives.

Results

Twelve National Tuberculosis Programme managers from high burden countries were interviewed about the scope of PPM partnerships. Understanding of PPM and types of engaged providers varied considerably; 'private-for-profit qualified clinical providers' were the dominant category. The literature review yielded information on 22 projects in which 'private-for-profit qualified clinical providers' were again the dominant category. The contributions made by 'private-for-profit qualified clinical providers' and 'Non Governmental Organisation qualified clinical providers', were assessed against the four global PPM objectives. Reporting on tuberculosis case detection and treatment outcomes was generally good and demonstrated important PPM contributions in these areas. Reporting on equity, access and reduced patient costs was often lacking or inconclusive.

Conclusions

PPM has improved case detection and treatment outcomes among patients seeking care with private providers. Evidence on reducing patient costs is inconclusive, and there is scope for increasing equity in access to care by systematically engaging those providers who are the primary agents for poor people seeking health care. Guidelines outlining which types of providers best contribute to achieving the four global objectives, along with the resources required by National Tuberculosis Programs for such engagement is needed.

  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. World Health Organization: Global Tuberculosis Control 2009: Surveillance, Planning, Financing. Geneva; 2009.
    • 2. Lopez De Fede A, Stewart JE, Harris MJ, Mayfield-Smith K: Tuberculosis in socio-economically deprived neighborhoods: missed opportunities for prevention. Int J Tuberc Lung Dis 2008, 12:1425-30.
    • 3. Hoa AB, Tiemersma EW, Sy DN, Nhung NV, Gebhard A, Borgdorff MW, Cobelens FGJ: Household expenditure and tuberculosis prevalence in VietNam: prediction by a set of household indicators. Int J Tuberc Lung Dis 2011, 15:32-7.
    • 4. World Health Organization: Tuberculosis Programme: framework for effective tuberculosis control (WHO/TB/94.179) Geneva; 1994.
    • 5. World Health Organization: DOTS.[http://who.int/tb/dots/en/].
    • 6. World Health Organization: Case Detection.[http://www.who.int/whosis/ indicators/2007TBCasesDetectedDOTS/en/index.html].
    • 7. World Health Organization: Treatment of tuberculosis: Guidelines - 4th ed. (WHO/HTM/TB/2009.420) Geneva; 2009.
    • 8. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P: Tuberculosis patients and practitioners in India. Int J Tuberc Lung Dis 1998, 2:324-9.
    • 9. Uplekar M, Pathania V, Raviglione M: Private practitioners and public health: weak links in tuberculosis control. Lancet 2001, 358:912-6.
    • 10. Uplekar M: Involving private health care providers in delivery of TB care: global strategy. Tuberculosis 2003, 83:156-64.
    • 11. Tuberculosis Coalition for Technical Assistance: International Standards for Tuberculosis Care The Hague; 2006.
    • 12. Chakaya JM, Meme H, Kamanga D, Githui WA, Onyango-Ouma WO, Gicheha C, et al: Planning for PPM-DOTS implementation in urban slums in Kenya: knowledge, attitude and practices of private health care providers in Kibera slum, Nairobi. Int J Tuberc Lung Dis 2005, 9:403-8.
    • 13. Salim MAH, Uplekar M, Daru P, Aung M, Declercq E, Lonnroth K: Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh. Bull World health Organ 2006, 84:479-84.
    • 14. Probandari A, Utarini A, Hurtig AK: Achieving quality in the Directly Observed Treatment Short-course (DOTS) strategy implementation process: a challenge for hospital Public-Private Mix in Indonesia. Glob Health Action 2008, 17:1.
    • 15. Probandari A, Lindholm L, Stenlund H, Utarini A, Hurtig AK: Missed opportunity for standardized diagnosis and treatment among adult tuberculosis patients in hospitals involved in Public-Private Mix for Directly Observed Treatment Short-Course strategy in Indonesia: a crosssectional study. BMC Health Services Research 2010, 10:113.
    • 16. World Health Organization, The STOP TB Partnership: The STOP TB Strategy: Building on and enhancing DOTS to meet the TB-related Millennium Development Goals (WHO/HTM/TB/2006.368) Geneva; 2006.
    • 17. World Health Organization: Public-Private Mix for TB Care and Control A Toolkit. (WHO/HTM/TB/2010.12) Geneva; 2010.
    • 18. World Health Organization, STOP TB Partnership: DOTS Expansion Working Group Strategic Plan 2006-2015 Geneva; 2006.
    • 19. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC: Tuberculosis control and elimination 2010-2050: cure, care, and social development. Lancet 2010, 375:1814-29.
    • 20. Marais BJ, Raviglione MC, Donald PR, Harries AD, Kritski AL, Graham SM, ElSadr WM, Harrington M, Churchyard G, Mwaba P, Sanne I, Kaufmann SH, Whitty CJ, Atun R, Zumla A: Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action. Lancet 2010, 375:2179-91.
    • 21. Raviglione MC, Uplekar M: WHO's new Stop TB Strategy. Lancet 2006, 367:952-55.
    • 22. Maher D, Dye C, Floyed K, Pantoja A, Lönnroth K, Reid A, Nathanson E, Pennas T, Fruth U, Cunningham J, Ignatius H, Raviglione MC, Koek I, Espinal M: Planning to improve global health: the next decade of tuberculosis control. Bull World Health Organ 2007, 85:341-47.
    • 23. Dye C, Maher D, Weil DEC, Espinal M, Raviglione M: Targets for global tuberculosis control. Int J Tuberc Lung Dis 2006, 10:460-62.
    • 24. World Health Organization: Engaging all Health Care Providers in TB Control: Guidance on Implementing Public-Private Mix Approaches Geneva; 2006.
    • 25. Rylance J, Pai M, Lienhardt C, Garner P: Priorities for tuberculosis research: a systematic review. Lancet Infect Dis 2010, 10:886-92.
    • 26. Atun R, Weil DEC, Eang MT, Mwakyusa D: Health-system strengthening and tuberculosis control. Lancet 2010, 375:2169-78.
    • 27. Uplekar M: Involving private health care providers in delivery of TB care: global strategy. Tuberculosis 2003, 83:156-164.
    • 28. Uplekar M, Pathania V, Raviglione M: Private practitioners and public health: weak links in tuberculosis control. Lancet 2001, 358:912-916.
    • 29. Lonnroth K, Uplekar M, Arora VK, Juvekar S, Lan NTN, Mwaniki D, Pathania V: Public-private mix for DOTS implementation: what makes it work? Bull World Health Organ 2004, 82:580-86.
    • 30. Lonnroth K, Uplekar M, Blanc L: Hard gains through soft contracts: productive engagement of private providers in tuberculosis control. Bull World Health Organ 2006, 84:876-83.
    • 31. Dewan PK, Lal SS, Lonnroth K, Wares F, Uplekar M, Sahu S, Granich R, Chauhan LS: Improving tuberculosis control through public-private collaboration in India: literature review. BMJ 2006, 332:574-578.
    • 32. Pantoja A, Floyd K, Unnikrishnan KP, Jitendra R, Padma MR, Lal SS, Uplekar M, Chauhan LS, Kumar P, Sahu S, Wares F, Lonnroth K: Economic evaluation of public-private mix for tuberculosis care and control, India. Part I. Socio-economic profile and costs among tuberculosis patients. Int J Tuberc Lung Dis 2009, 13:698-704.
    • 33. Pantoja A, Lonnroth K, Lal SS, Chauhan LS, Uplekar M, Padma MR, Unnikrishnan KP, Rajesh J, Kumar P, Sahu S, Wares F, Floyd K: Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness. Int J Tuberc Lung Dis 2009, 13:705-712.
    • 34. Floyd K, Arora VK, Murthy KJR, Lonnroth K, Singla N, Akbar Y, Zignol M, Uplekar M: Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bull World Health Organ 2006, 84:479-84.
    • 35. Ferroussier O, Kumar MKA, Dewan PK, Nair PKJ, Sahu S, Wares DF, Laserson K, Wells C, Granich R, Chauhan LS: Cost and cost-effectiveness of a public-private mix project in Kannur District, Kerala, India, 2001-2002. Int J Tuberc Lung Dis 2007, 11:755-761.
    • 36. Flores L, Steingart K, Dendukuri N, Schiller I, Minion J, Pai M, Ramsay A, Henry M, Laal S: Antigen detection tests for the diagnosis of tuberculosis: A systematic review and meta-analysis. Clin Vaccine Immunol 2011, PMID: 21832100.
    • 37. Long Q, Smith H, Zhang T, Tang S, Garner P: Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC Public Health 2011, 11:393.
    • 38. Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ: Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS One 2011, 6:e17601.
    • 39. Bosch-Capblanch X, Garner P: Primary health care supervision in developing countries. Trop Med Int Health 2008, 13:369-83.
    • 40. Malmborg R, Mann GH, Thomson R, Squire SB: Can public-private collaboration promote tuberculosis case detection among the poor and vulnerable? Bull World Health Organ 2006, 84:752-8.
    • 41. StopTB partnership Public-Private Mix (PPM) for TB Care and Control. [http://www.stoptb.org/wg/dots_expansion/ppm/].
    • 42. Whiting P: Quality of diagnostic accuracy studies: the development, use, and evaluation of QUADAS. Bristol; 2006.
    • 43. Critical Appraisal Skills Programme (CASP). [http://www.casp-uk.net/].
    • 44. Kumar MKA, Dewan PK, Nair PKJ, Frieden TR, Sahu S, Wares F, Laserson K, Wells C, Granich R, Chauhan LS: Improved tuberculosis case detection through public-private partnership and laboratory-based surveillance, Kannur District, Kerala, India, 2001-2002. Int J Tuberc Lung Dis 2005, 9:870-876.
    • 45. Tugwell P, Petticrew M, Kristjansson E, Welch V, Ueffing E, Waters E, Bonnefoy J, Morgan A, Doohan E, Kelly MP: Assessing equity in systematic reviews: realising the recommendations of the Commission on Social Determinats of Health. BMJ 2010, 341:c4739.
    • 46. Pathak PK, Singh A, Subramanian SV: Economic Inequalities in Maternal Health Care: Prenatal Care and Skilled Birth Attendance in India, 1992- 2006. PLoS One 2010, 5:e13593.
    • 47. Mobile Phones & Financial Incentives to Increase TB Case Detection. [http://www.mhealthinfo.org/project/mobile-phones-financial-incentivesincrease-tb-case-detection].
    • 48. Arora VK, Sarin R, Lonnroth K: Feasibility and effectiveness of a publicprivate mix project for improved TB control in Delhi, India. Int J Tuberc Lung Dis 2003, 7:1131-1138.
    • 49. Rangan SG, Juvekar SK, Rasalpurkar SB, Morankar SN, Joshi AN, Porter JDH: Tuberculosis control in rural India: lessons from public-private collaboration. Int J Tuberc Lung Dis 2004, 8:552-559.
    • 50. Maung M, Kluge H, Aye T, Maung W, Noe P, Zaw M, Jost SP, Uplekar M, Lonnroth K: Private GPs contribution to TB control in Myanmar: evaluation of a PPM initiative in Mandalay Division. Int J Tuberc Lung Dis 2006, 10:982-987.
    • 51. Lonnroth K, Aung T, Maung W, Kluge H, Uplekar M: Social franchising of TB care through private GPs in Myanmar: an assessment of treatment results, access, equity and financial protection. Heath Policy and Planning 2007, 22:156-166.
    • 52. Newell JN, Pande SB, Baral SC, Bam DS, Malla P: Leadership, management and technical lessons learnt from a successful public-private partnership for TB control in Nepal. Int J Tuberc Lung Dis 2003, 9:1013-1017.
    • 53. Ardian M, Meokbun E, Siburian L, Malonda E, Waramori G, Penttinen P, Lempoy J, Kenangalem E, Tjitra E, Kelly PM: A public-private partnership for TB control in Timika, Papua Province, Indonesia. Int J Tuberc Lung Dis 2007, 11:1101-1107.
    • 54. World Health Organization: Tuberculosis Services in Partnership; The Case of Egypt. WHO-EM/TUB/243/E Cairo; 2004.
    • 55. Sheikh K, Porter J, Kielmann K, Rangan S: Public-private partnerships for equity of access to care for tuberculosis and HIV/AIDS: lessons from Pune, India. Trstmh 2006, 100:312-320.
    • 56. Ahmed J, Ahmed M, Langhari A, Lohana W, Ali S, Fatmi Z: Public private mix model in enhancing tuberculosis case detection in District Thatta, Sindh, Pakistan. J Pak Med Assoc 2009, 59:82-86.
    • 57. Quy HT, Lonnroth K, Lan NTN, Buu TN: Treatment results among tuberculosis patients treated by private lung specialists involved in a public-private mix project in Vietnam. Int J Tuberc Lung Dis 2003, 7:1139-1146.
    • 58. Gidado M, Ejembi CL: Tuberculosis case management and treatment outcome: Assessment of the effectiveness of public - private mix of tuberculosis programme in Kaduna state, Nigeria. Ann Afr Med 2009, 8:25-31.
    • 59. Anuradha B, Priya VHS, Lakshmi VV, Akbar Y, Aparna S, Latha GS, Murthy KJR: Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003. Int J Tuberc Lung Dis 2006, 10:58-62.
    • 60. Copreaux J, Dholakia YN: Tuberculosis Control Involvement of Private Medical Sector One to One Approach: Mumbai Experience Delhi: Inter AIDE UCITC report; 2003.
    • 61. Ambe G, Lonnroth K, Dholakia Y, Copreaux J, Zignol M, Borremans N, Uplekar M: Every provider counts: effect of a comprehensive publicprivate mix approach for TB control in a large metropolitan area in India. Int J Tuberc Lung Dis 2005, 9:562-568.
    • 62. Sinanovic E, Kumaranayake L: Quality of care provided in different models of public-private partnerships in South Africa. Int J Tuberc Lung Dis 2006, 10:795-801.
    • 63. Hurtig AK, Pade SB, Baral SC, Newell J, Porter JDH, Bam DS: Linking private and public sector in tuberculosis treatment in Kathmandu Vally, Nepal. Health Policy and Plan 2002, 17:78-89.
    • 64. Quelapio MID, Mira NRC, Orillaza-Chi RB, Belen V, Munez N, Belchez R, Egos GE, Evangelista M, Vianzon R, Tupasi TE: Responding to the multidrug-resistant tuberculosis crisis: mainstreaming programmatic management to the Philippine National Tuberculosis Programme. Int J Tuberc Lung Dis 2010, 14:751-757.
    • 65. Chakaya J, Uplekar M, Mansoer J, Kutwa A, Keranja G, Ombeka V, Muthama D, Kimuu P, Odhiambo J, Njiru H, Kibuga D, Sitienei J: Publicprivate mix for control of tuberculosis and TB-HIV in Nairobi, Kenya: outcomes, opportunities and obstacles. Int J Tuberc Lung Dis 2008, 12:1274-1278.
    • 66. Newell JN, Pande SB, Baral SC, Bam DS, Malla P: Control of tuberculosis in an urban setting in Nepal: public-private partnership. Bull World Health Organ 2004, 82:92-98.
    • 67. Murthy KJR, Frieden TR, Yazdani A, Hreshikesh P: Public-private partnership in tuberculosis control: experience in Hyderabad, India. Int J Tuberc Lung Dis 2001, 5:354-359.
    • 68. Krishnan N, Ananthakrishnan R, Augustine S, Vijayalakshmi NK, Gopi PG, Kumaraswami V, Narayanan PR: Impact of advocacy on the tuberculosis management practices of private practitioners in Chennai City, India. Int J Tuberc Lung Dis 2009, 13:112-118.
    • 69. Greaves F, Ouyang H, Pefole M, Cash RA: Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India. Int J Tuberc Lung Dis 2007, 11:110-112.
    • 70. Quy HT, Lan NTN, Lonnroth K, Buu TN, Dieu TTN, Hai LT: Public-private mix for improved TB control in Ho Chi Minh City, Vietnam: an assessment of its impact on case detection. Int J Tuberc Lung Dis 2003, 7:464-471.
    • 71. Lonnroth K, Karlsson M, Lan NTN, Buu TN, Dieu TTN: Referring TB suspects from private pharmacies to the National Tuberculosis Programme: experiences from two districts in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2003, 7:1147-1153.
    • 72. Gabrysch S, Cousens S, Cox J, Campbell OM: The influence of distance and level of care on delivery place in rural Zambia: a study of linked national data in a geographic information system. PloS Med 2011, 8: e1000394.
    • 73. Cooke GS, Tanser FC, Bärnighausen TW, Newell ML: Popolation uptake of antiretroviral treatment through primary care in rural South Africa. BMC Public Health 2010, 29:585.
    • 74. Roeger LS, Reed RL, Smith BP: Equity of access in the spatial distribution of GPs within an Australian metropolitan city. Aust Prim Health 2010, 16:284-90.
    • 75. Salim Mah, Uplekar M, Daru P, Aung M, Declercq E, Lonnroth K: Turning liabilities into resources: informal village doctors and tuberculosis control in Bangladesh. Bull World Health Organ 2006, 84:479-84.
    • 76. Sehgal S, Dewan PK, Chauhan LS, Sahu S, Wares F, Granich R: Publicprivate mix TB activities in Meerut, Uttar Pradesh, north India: Delivering DOTS via collaboration with private providers and non-governmental organizations. Indian J Tuberc 2007, 54:79-83.
    • 77. Chaudhury RR, Thatte U: Beyond DOTS: Avenues ahead in the management of tuberculosis. Natl Med J India 2003, 16:321-7.
    • 78. Udwadia ZF, Pinto LM, Uplekar M: Tuberculosis Management by Private Practitioners in Mumbai, India: Has Anything Changed in Two Decades? PLoS One 2010, 5:e12023.
    • 79. Arora VK, Gupta R: Private-Public Mix: A Prioritisation Under RNTCP-An Indian Perspective. Indian J Chest Dis Allied Sci 2004, 46:27-37.
    • 80. Arora VK, Lonnroth K, Sarin R: Improved Case Detection of Tuberculosis Through a Public-Private Partnership. Indian J Chest Dis Allied Sci 2004, 46:133-136.
    • 81. Irawati SR, Basri C, Arias MS, Prihatini S, Rintiswati N, Voskens J, Kimerling ME: Hospital DOTS linkage in Indonesia: a model for DOTS expansion into government and private hospitals. Int J Tuberc Lung Dis 2007, 11:33-39.
    • 82. Quelapio MID, Mira NRC, Abeleda MR, Rivera AB, Tupasi TE, Grimaldo ER, Mangubat NV, Belen VA, Derilo JO: Directly Observed Therapy-ShortCourse (DOTS) at the Makati Medical Center. Phil J Microbiol Infect Dis 2000, 29:80-86.
    • 83. Mantala MJ: Public-Private mix DOTS in the Philippines. Tuberculosis 2003, 83:173-176.
  • No related research data.
  • No similar publications.